252 results about "Bifidobacterium breve" patented technology

A mixture of at least 6 species of lactic acid bacteria and / or Bifidobacteria is disclosed for use in bakery and medical field. The preferred mixture comprises Streptococcus thermophilus, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium breve, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus delbrueckii subsp. bulgaricus. Said mixture is useful for a sourdough, a leavening composition. Baked goods and other food products obtained therefrom are disclosed. These goods have low or no gluten content and are suitable for the integration of the diet of a subject suffering from celiac disease, for decreasing the risk of allergies due to wheat flour albumins and globulins, for the treatment of schizophrenic symptoms, in the preparation of products for enteric diet.

There is provided a preparation comprising Bifidobacterium breve and a mixture of non-digestible carbohydrates for non- or partially breast-fed infants as well as the use thereof for the treatment or prevention of immune disorder in non- or partially breast-fed infants. Also provided herein are sequence primers and probe for the detection of Bifidobacterium species as well as diagnostic kit thereof.

This invention relates to a composition suitable for use in the prevention of opportunistic infections in immune-compromised individuals comprising a probiotic Bifidobacterium lactis, Bifidobacterium infantis, Bifidobacterium breve or Bifidobacterium longum and a fucosylated oligosaccharide selected from the group comprising 2′-fucosyllactose, 3′fucosyllactose, difucosyllactose, lacto-N-fucopentaose, lacto-N-fucohexaose, fucosyllacto-N-hexaose and fucosyllacto-N-neohexaose. The invention further extends to the use of such a composition in the prevention of opportunistic infections in immune-compromised individuals.

The invention relates to a drink, in particular to a probiotic type fruit and vegetable enzyme solid drink. The probiotic type fruit and vegetable enzyme solid drink is prepared from raw materials in parts by mass as follows: 10-50 parts of prebiotics, 5-40 parts of water-soluble dietary fiber, 0-20 parts of sugar alcohol, 0.1-15 parts of fruit powder, 0.1-10 parts of fruit and vegetable enzyme powder, 0.01-15 parts of freeze-dried bifidobacterium infantis powder, 0.01-20 parts of freeze-dried bifidobacterium breve powder, 0.01-30 parts of freeze-dried Lactobacillus plantarum powder, 0.01-25 parts of freeze-dried bifidobacterium longum powder and 0.01-20 parts of freeze-dried Lactobacillus casei powder. The probiotic type fruit and vegetable enzyme solid drink adopts the natural raw materials and the scientific formula and is balanced in nutrition and beneficial to intestinal health and body immunity.

The invention provides an acid-resistant bifidobacterium breve BB8dpH and an application thereof. The nucleotide sequence of the 16SrRNA gene part of the bifidobacterium breve BB8dpH is shown in SEQ ID NO.1, and is stored with the preservation number of CGMCCNo.8370. The bifidobacterium breve BB8dpH is a strain obtained by separating from the dejecta of healthy young people and further screening under the pH 3.2 acid condition. According to the fermentation and culturing process, anaerobic culture at 37 DEG C is carried out in a BL liquid substrate (containing 0.05% cysteine hydrochloride) for 24 hours. The bifidobacterium breve BB8dpH has remarkably better acid resistance than the common strains, and the acid resistance has genetic stability; the bifidobacterium breve BB8dpH has different percent contents of cell membrane fatty acids from the common strains, the average carbon chain length of the bifidobacterium breve BB8dpH is remarkably longer than that of the common strains, and the cell membrane fluidity of the bifidobacterium breve BB8dpH is remarkably lower than that of the common strains; and the bifidobacterium breve BB8dpH is used in the production field of daily fermented food, health-care food and medicines.

The present invention relates to the use of Bifidobacterium breve for reduction of asthma and asthma like symptoms later in life and in reducing use of asthma medication.

This invention relates to Bifidobacterium breve CNCM I-3865, to a composition comprising Bifidobacterium breve CNCM I-3865 and to the use of Bifidobacterium breve CNCM I-3865 in the prevention or treatment of rotavirus diarrhoea. prevention and treatment of rotavirus diarrhoea

An infant and / or toddler nutrition comprising non-viable Bifidobacterium breve and a non-digestible oligosaccharide and its use are disclosed.

The invention provides a microbial freezing drying protective agent using stachyose as one of main components in the protective agent. The protective agent consists of 0.8-3.5% of stachyose, 0.1-0.6%of sodium glutamate, 0.4-1.5% of galactose and 6-15% of skim milk powder. In the invention, the stachyose is applied to freeze, dry and protect strains and used as one of components of a freeze-dryingprotective agent so as to widen the application of the stachyose. Advantages of the stachyose, sodium glutamate and the like are mutually complemental to form favorable combinations of the freeze-drying protective agent. The invention has higher freeze-drying protective efficiency and stable protective effect to various bifidobacterium such as bifidobacterium breve, bifidobacterium adolesentis and the like and various lactobacillus such as lactic acid bacillus, lactococcus and the like. The invention solves the problems that freeze-drying protective agent is complicated, and the differences of protective effects are great in the study of microbial formulations and provides favorable compositions of the protective agent for the preservation of probiotics such as bifidobacterium, lactobacillus, saccharomycetes and the like, thereby being beneficial to preserving the strain stably.

A composition comprising Bifidobacterium breve, a non-digestible saccharide A and a non-digestible saccharide B, optionally combined with Lactobacillus paracasei and the use of said composition for the treatment and / or prevention of gastrointestinal disorder, immune disorder and / or endocrine disorder.

The invention discloses a novel Bifidobacterium breve with excellent probiotic function. The Bifidobacterium breve strains are obtained by screening the feces of the long-lived elders in Hetian, XinJiang, and the obtained strains have outstanding resistance to acid and bile acid salts, adhesion characteristics to intestinal tract epidermic cells, excellent antibacterial performance and good oxidization resistance; and the strains have an effect on reducing the blood pressure as well as the edible safety, therefore, the Bifidobacterium breve can be widely applied in the fields such as functional additives, dairy products, beverage, functional food, drug production, etc.

The invention relates to bifidobacterium breve C11 (CCFM683) and application thereof. According to the invention, bifidobacterium breve C11 (CCFM683) can respectively effectively converter free linoleic acid and linolenic acid into conjugated linoleic acid and conjugated linolenic acid with better biological activity, can be directly used for preparing conjugated linoleic acid or conjugated linolenic acid, and can also be used for producing food rich in conjugated linoleic acid or conjugated linolenic acid.

The invention relates to a probiotic composition, and discloses a probiotic composition beneficial for a glycolipid metabolic function and a preparation and application of the composition. The probiotic composition comprises some of the following nine probiotics: bifidobacterium longum, bifidobacterium breve, lactobacillus gasseri, lactobacillus rhamnosus, lactobacillus salivarius, lactobacillus crispatus, lactobacillus plantarum, lactobacillus fermentum and lactobacillus casei. Different strains in the probiotic composition cooperate with each other, so that the probiotic composition has thefunction of adjusting glycolipid metabolism, and has certain effect on serum total cholesterol, triglycerides, insulin beta-cell functions and diabetes mellitus improvement.

The invention relates to bifidobacterium breve CCFM1025, a fermented food and application thereof. The bifidobacterium breve CCFM1025 can be used for improving the depression-like behavior of a depression mouse, improving 5-hydroxytryptamine in the brain of the depression mouse, improving the level of 5-hydroxytryptamine and a brain-derived neurotrophic factor, reducing the level of corticosteronein serum of the depression mouse, improving the level of 5-hydroxytryptamine in the serum of the depression mouse, improving intestinal flora disturbance of the depression mouse, reducing the abundance of intestinal veillonella, improving the abundance of bifidobacterium and mycoplasmataceae, improving alpha-diversity of intestinal flora and reducing occurrence of inflammatory bowel disease and obesity. By adopting the bifidobacterium breve CCFM1025, the mRNA level of tryptophan hydroxylase in a simulated entero-chromaffin cell can be improved, the secretion volume of 5-hydroxytryptophane ofthe cell can be improved, and a precursor substance is specifically provided to synthesis of 5-hydroxytryptamine in the brain. The bifidobacterium breve CCFM1025 has a wide application prospect.

The invention relates to a composite microecological preparation which comprises bacillus natto, candida utilis, lactobacillus plantarum, bifidobacterium breve and oligosaccharide. The composite microecological preparation is prepared from the following raw materials by weight percent: 5-30% of bacillus natto, 1-20% of candida utilis, 3-25% of lactobacillus plantarum, 1-15% of bifidobacterium breve, 10-60% of oligosaccharide and 0.5-10% of other auxiliary materials. The oligosaccharide comprises one or more of fructo-oligosaccharide, xylo-oligosaccharide, lactosyl fructoside, soybean oligosaccharide and inulin. The probiotics are combined with the prebiotics, so that the rapid planting growth of the probiotics can be promoted in the intestinal tract of the organism, the microbial balance of the intestinal tract can be rapidly adjusted, dysentery and diarrhea of the poultry can be effectively controlled, the growth of the poultry is promoted, and the immunity of the organism is improved.

The invention provides an integrated probiotic product comprising lactoferrin, inulin, bromelain and a white radish extract. The integrated probiotic product is rich in lactobacillus acidophilus, bifidobacterium infantis, bifidobacterium longum, bifidobacterium breve, bifidobacterium bifidum, lactobacillus rhamnosus, lactobacillus bulgaricus, lactobacillus plantarum, lactobacillus casei, lactobacillus paracasei, streptococcus thermophilus and other intestinal probiotics; the effective substances, such as lactoferrin, inulin, bromelain and the white radish extract, are added in the integrated probiotic product, and the colonization of intestinal probiotics is facilitated, and establishing and maintenance of healthy intestinal flora are facilitated; the composition also has anti-inflammatory and immunoregulation effects.

The invention discloses a micro-ecological composition for improving constipation by targeting intestinal flora and a preparation of the micro-ecological composition. The micro-ecological compositioncomprises probiotics, prebiotics and medicinal and edible traditional Chinese medicines, wherein the probiotics are selected from at least one of bifidobacterium animalis, bifidobacterium adolescentis, bifidobacterium longum, bifidobacterium breve, lactobacillus rhamnosus, lactobacillus acidophilus, lactobacillus helveticus, lactobacillus plantarum, lactobacillus reuteri, lactobacillus paracasei and bacillus coagulans; the prebiotics are selected from at least one of stachyose, fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, inulin, resistant dextrin and xylooligosaccharide; and the medicinal and edible traditional Chinese medicines are selected from at least one of semen sesami nigri, semen cassiae, fructus cannabis, honey, semen lablab album, semen coicis, poria cocos and lotus leaves. The micro-ecological composition can effectively regulate intestinal tract micro-ecology in a targeted mode, and finally the purpose of improving constipation is achieved.

The invention relates to the technical field of probiotics, particularly to sugar-free probiotics powder and a preparation method thereof. The sugar-free probiotics powder comprises water-soluble dietary fibers, fructo-oligosaccharides, xylooligosaccharides, stachyose, Lactobacillus acidophilus powder, Lactobacillus plantarum powder, Lactobacillus rhamnosus powder, Lactobacillus casei powder, Bifidobacterium bifidum powder, Bifidobacterium breve powder and Bifidobacterium lactis powder. Compared with the prior art, the sugar-free probiotics powder and the preparation method thereof have the advantages that a formula and the preparation method of the probiotics powder are designed, the probiotics powder has the sugar-free characteristic, a user is prevented from ingesting excessive sugar while supplemented with a large quantity of probiotics prebiotics, on one hand, the obesity probability is reduced, and on the other hand, special groups suffering from diabetes and the like can also take the powder. The powder has the characteristics of good solubility, good taste, natural raw material, scientific formula and balanced nutrition.

The invention discloses a probiotics-Chinese herbal medicine compound composition capable of loosening bowels to relieve constipation and application of the probiotics-Chinese herbal medicine compoundcomposition and belongs to the technical field of health-care foods. The composition comprises 13-15 kinds of lactobacillus rhamnosus, lactobacillus plantarum, lactobacillus paracasei, bifidobacterium lactis, lactobacillus acidophilus, bifidobacterium longum, lactobacillus reuteri, lactobacillus helveticus, lactobacillus fermentum, lactobacillus johnsonii, lactobacillus casei, lactobacillus crispatus, bifidobacterium breve, bifidobacterium bifidum and bifidobacterium infantis, 10-13 kinds of isomalto-oligosaccharide, inulin, lactitol, stachyose, fructo-oligosaccharide, xylo-oligosaccharide, Mannan-oligosaccharide, galacto-oligosaccharide, oat beta-glucan, glucan, soluble soybean polysaccharide, resistant dextrin and chitosan-oligosaccharide and 2-4 kinds of malts, fructus crataegi, blackplums and fermented soybeans. According to the probiotics-Chinese herbal medicine compound composition and the application thereof, probiotics, prebiotics and traditional Chinese medicine powder are compounded and can jointly promote intestinal canal health.

An anti-obesity strain of lactic acid bacteria and uses in food and pharmaceutical compositions are disclosed. Isolated lactic acid bacteria strains which are CP-9 (Bifidobacterium longum) and / or bv-77 (Bifidobacterium breve) are provided. The present invention provides the novel strains of lactic acid bacteria and novel compositions having fat reducing / weight reducing capabilities containing the present strains. The compositions may be used in the form of food or pharmaceutical compositions.

The invention discloses a plant composite ferment capable of adjusting intestinal floras and a preparation method thereof. The plant composite ferment is mainly prepared by uniformly mixing botanical raw materials consisting of black fungi, citrus fiber, oat bran and konjak powder according to a certain weight ratio, then adding probiotics for fermentation and carrying out blending with prebiotics and dietary fiber, wherein probiotics are one or more selected from a group consisting of Bifidobacterium adolescentis, Bifidobacterium lactis, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium bifidum, Lactobacillus acidophilus, Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp. diacetyl, Leuconostoc mesenteroides subsp. mesenteroides, conventional bacterial strains for food production and processing, etc.; and the prebiotics and dietary fiber are one or more selected from a group consisting of inulin, L-arabinose and stachyose. The plant composite ferment provided by the invention can provide beneficial bacteria for the intestinal tracts of people, is applicable as a raw material for metabolism of intestinal floras and has good effect on adjustment of the functions of intestinal floras.

The invention relates to the technical field of food enzymes, and discloses a symbiotic microflora enzyme. The symbiotic microflora enzyme contains symbiotic microflora which has the effect of preventing, resisting and inhibiting helicobacter pylori. The symbiotic microflora contains main microflora and auxiliary microflora which aim at enhancing microflora effects and increasing the microflora number, wherein the main microflora comprises lactobacillus acidophilus, lactobacillus bulgaricus, lactobacillus plantarum, lactobacillus rhamnosus, Roy's lactobacillus, lactobacillus casei, lactobacillus gasseri, lactobacillus johnsonii, lactobacillus salivarius, lactobacillus brevis, lactic streptococci, bacillus subtilis, bifidobacterium bifidum, bifidobacterium adolescentis, bifidobacterium infantis, bifidobacterium breve and bifidobacterium longum. After the symbiotic microflora enzyme is drunk, the contained powerful and rich symbiotic microflora can naturally exist in the digestive system of the human body, obtains the living space advantage in the ecological environment, and achieves the effect of eliminating helicobacter pylori.

The invention discloses a composite probiotic beverage for dispelling the effects of alcohol and special composite probiotic thereof. The composite probiotic is composed of streptococcus thermophilus,lactobacillus paracasei, lactobacillus acidophilus, lactobacillus bulgaricus, lactobacillus plantarum, bifidobacterium longum and bifidobacterium breve according to a CFU ratio of 2: 3: 4: 1: 1: 1: 3. The composite probiotic beverage for dispelling the effects of alcohol is composed of composite probiotic powder, prebiotics, amino acid and fruit powder. Through use of seven kinds of active probiotics, the composite probiotic beverage can adjust the balance of intestinal flora, improve the immunity of the human body, effectively remove acetaldehyde in the small intestine and colon and relievethe symptoms of headache, dizziness and the like caused by drinking, can be colonized in the intestines, can prevent intestinal flora disturbance caused by drinking, can reduce liver cell damage and can effectively protect liver health. The probiotics contain alcohol dehydrogenase and acetaldehyde dehydrogenase and can effectively decompose alcohol through synergizing with human alcohol dehydrogenation and acetaldehyde dehydrogenase.

The invention belongs to the technical field of microbial fermented beverages. In order to solve the problems of relatively few research reports of anthocyanidin-containing pure microbial fermented beverages in the prior food and beverages and lack of anthocyanidin-containing pure microbial fermented beverages which are also medicinal and edible functional health care beverage products, the invention provides a compound microbial fermented beverage containing anthocyanidin and a preparation method thereof. The compound microbial fermented beverage is prepared by mixing purple sweet potatoes, grapes, blueberries, strawberries, mulberries, haws and water in a certain proportion, performing fermentation with a microbial starter culture prepared from lactobacillus plantarum, lactobacillus rhamnosus, lactobacillus acidophilus, bifidobacterium breve and saccharomyces cerevisiae and adding collagen polypeptides and stachyose. The compound microbial fermented beverage provided by the inventioncan resist oxidation, prevent mutation, resist allergies, prevent cardiovascular and cerebrovascular diseases, protect the liver, prevent cancer, improve eyesight, eliminate harmful free radicals invivo, improve sleep, promote the proliferation of beneficial bacteria in vivo and inhibit the reproduction of harmful bacteria and has a good auxiliary treating effect on various kinds of chronic diseases.

The invention relates to probiotics powder for regulating constipation and a preparation method thereof, and belongs to the technical field of food processing and production. Raw materials include a plurality of beneficial substances of lactobacillus rhamnosuslyophilized powder, bifidobacterium longum lyophilized powder, lactobacillus plantarum lyophilized powder, lactobacillus acidophilus lyophilized powder, bifidobacterium breve lyophilized powder, bifidobacterium lactis lyophilized powder, sorbitol, resistant dextrin, lactitol, oligofructose, stachyose and the like. At the same time, the preparation process is improved, and the raw materials are separately divided into several parts to prepare mixed powder and then further mixed with other raw materials. An obtained solid beverage not only has a certain conditioning effect on the constipation, but also has excellent product properties, and is not prone to moisturize and agglomerate. The solubility, uniformity and full powder yield are high.

The invention relates to nutritional compositions with Bifidobacterium breve and non-digestible oligosaccharides selected from the group consisting of fructo-oligosaccharides, galacto-oligosaccharides, gluco-oligosaccharides, arabino-oligosaccharides, mannan-oligosaccharides, xylo-oligosaccharides, fuco-oligosaccharides, arabinogalacto-oligosaccharides, glucomanno-oligosaccharides, galactomanno-oligosaccharides, sialic acid comprising oligosaccharides and uronic acid oligosaccharides for use in improving cognitive or behavioral performance, cognitive or behavioral development, social interaction and / or neuroinflammation in infants or toddlers. Also claimed is the use of a nutritional compositions including Bifidobacterium breve, at least one non digestible oligosaccharide, glutamine in the form of free amino acids and / or glutamine containing dipeptide and / or glutaime containing tripeptide and LC-PUFA in the form or arachidonic acid and / or docosahexaenoic acid. Also claimed is a kit of parts comprising a first container comprising glutamine, and a non-digestible oligosaccharide and a second container comprising Bifidobacterium breve.

The present invention relates to bifidobacterium breve CCFM1025, its fermented food and application thereof. Bifidobacterium breve CCFM1025 of the present invention can improve the depression-like behavior of depressed mice, increase the levels of 5-hydroxytryptophan, 5-hydroxytryptophan and brain-derived neurotrophic factor in the brain of depressed mice, and reduce the levels of 5-hydroxytryptophan in the serum of depressed mice. Corticosterone levels, increased serum 5-hydroxytryptamine levels in depressed mice, improved intestinal flora disturbance in depressed mice, decreased intestinal Veillonellaceae abundance, increased the abundance of Bifidobacteria and Mycoplasmaceae , increase the α-diversity of intestinal flora, reduce the occurrence of inflammatory bowel disease and obesity; increase the mRNA level of tryptophan hydroxylase 1 in simulated enterochromaffin cells, and increase the level of 5-hydroxytryptophan in this cell Secretion, specifically providing precursors for the synthesis of 5-HT in the brain. It has broad application prospects.

This invention relates to a composition suitable for use in the prevention of opportunistic infections in immune-compromised individuals comprising a probiotic Bifidobacterium lactis, Bifidobacterium infantis, Bifidobacterium breve or Bifidobacterium longum and a fucosylated oligosaccharide selected from the group comprising 2′-fucosyllactose, 3′fucosyllactose, difucosyllactose, lacto-N-fucopentaose, lacto-N-fucohexaose, fucosyllacto-N-hexaose and fucosyllacto-N-neohexaose. The invention further extends to the use of such a composition in the prevention of opportunistic infections in immune-compromised individuals.

The invention provides a biological air freshener and a preparation method thereof and belongs to the technical field of biological fermentation. The preparation method of the biological air freshener comprises the following steps: culturing saccharomyces ellipsoideus, streptococcus thermophilus and a culture medium for 12-48 h at the normal temperature and the normal pressure; adding torula utilis, lactobacillus fermentium, lactobacillus helveticus, bifidobacterium breve and lactobacillus bulgaricus, and culturing for 12-48 h at the normal temperature and the normal pressure; adding saccharomycesmanginii and lactobacillus acidophilus, and culturing for 12-48 h at the normal temperature and the normal pressure; adding bacillus subtilis, and culturing for 12-48 h at the normal temperature and the normal pressure; adding saccharomyces ellipsoideus, streptococcus thermophilus and lactobacillus bulgaricus, and culturing for 14-20 days at the normal temperature and the normal pressure in an oxygen isolated environment to obtain a fermentation liquor. The biological air freshener prepared by the preparation method is prepared by the pure natural materials, causes no irritation to a human body, and can realize decomposition, polymerization, substitution and other functions with various bad smell molecules to remove odor.

The invention belongs to the field of life sciences and food safety, and relates to bifidobacterium breve isolated from the intestinal tract of a healthy person and a method for detecting antibiotic residues in milk by means of the strain. The isolated strain is DSQH-1, and the preservation number is CGMCC No.8579; the DSQH-1 strain is sensitive to antibiotics such as penicillin, tetracycline and erythromycin. The method for detecting various antibiotic residues in milk by taking the strain as a working strain comprises the steps of strain activation, bacterial suspension preparation, screening culture medium preparation, quantitative detection culture medium preparation, standard tube preparation, standard curve drawing, sample preparation, sample screening and detecting, sample quantitative detection and the like. The method for detecting various antibiotic residues in milk is easy and convenient to operate, simple in equipment requirement, high in sensentivity, not prone to contamination and suitable for screening and quantitative detection of a large number of samples and can also be used for self inspection of producers.